Breast Cancer Radiation Therapy Non-Invasive Procedure.
Used in Healthcare and Oncology Centers Nationwide.
Medical Device with FDA Clearance, Patented Technology, and Clinical Evidence.
Projecting a $50M Ceiling, 40% EBITDA to Revenue, and 100% EBITDA Growth.
Offering: $20M for 100% or $5M for 25%
Principals Only. Confidential, must eMail Buyer/Investor Bio/Resume for more information. Principals Only!

Posted Mar 17, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.